VBI Vaccines Inc. 26,800,000 Common Shares (no par value per share) Underwriting AgreementUnderwriting Agreement • December 17th, 2018 • VBI Vaccines Inc/Bc • Pharmaceutical preparations • New York
VBI Vaccines Inc., a company incorporated under the Business Corporations Act (British Columbia) (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 26,800,000 common shares, no par value per share (the “Shares”). The 26,800,000 Shares to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 4,020,000 Shares as provided in Section 2. The additional 4,020,000 Shares that may be sold by the Company pursuant to such option are collectively called the “Optional Shares.” The Firm Shares and, if and to the extent such option is exercised, the Optional Shares, are collectively called the “Offered Shares.” BMO Capital Markets Corp. (“BMOCM”), Canaccord Genuity LLC (“Canaccord”) and Oppenheimer and Co., Inc. (“Oppenheimer”) have agreed to act as representatives of the several Underwriters (in such capacity, the “Represent
